Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
February 4, 2026 Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX...
-
HP Inc. and Karamba Security extend their XGuard licensing agreement by 3 more years, to harden HP's "the world most secure printers" against cyberattacks
-
Johnstown, PA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Concurrent Technologies Corporation (CTC) has successfully licensed its patented Metal Injection Molded (MIM) ammunition technology to Ultra Defense...
-
VANCOUVER, British Columbia, Feb. 02, 2026 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that the Company has signed a royalty-bearing...
-
Strategic amendment transforms regional partnership into global collaboration; Newsoara gains exclusive worldwide license to develop and commercialize novel PDE4 inhibitor vTv to receive $20 million...
-
Gameto announces the licensure of IP from Harvard University to genetically induce meiosis in stem cells
-
REYKJAVIK, Iceland, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients...
-
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced that it has entered into an exclusive, 20-year worldwide license...
-
NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced that it has entered into an exclusive, 20-year worldwide license...
-
60 Degrees Pharma licenses FSU technology to purify castanospermine and begins U.S. regulatory steps for non-Rx Australian Chestnut Extract.